研究者情報 | |
イケモリ アツコ
IKEMORI ATSUKO 池森敦子 所属 医学部医学科 解剖学(機能組織) 職種 主任教授 |
|
言語種別 | 英語 |
発表タイトル | Effect of Glucagon-like peptide-1, receptor agonist, liraglutide, against diabetic retinal edema in spontaneously diabetic tori fatty rats. |
会議名 | 第126回日本解剖学会総会・全国学術集会・第98回日本生理学会大会 合同大会 |
学会区分 | 全国規模の学会 |
発表形式 | ポスター掲示 |
講演区分 | 一般 |
発表者・共同発表者 | Inoue K, Yamada S, Hosino S, Shibagaki Y, Ikemori A |
発表年月日 | 2021/03/28 |
開催地 (都市, 国名) | Web開催 |
学会抄録 | 149 2021 |
概要 | Background:
The aim of this study is to investigate the effect of glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RA), liraglutide, against diabetic retinal edema using an animal model of type 2 diabetes. Methods: Male spontaneously diabetic torii (SDT) fatty rats at 8 weeks of age were randomly assigned to three groups; the liraglutide group has been subcutaneous injected liraglutide for 8 weeks. Other group was provided both insulin against hyperglycemia and hydralazine against hypertension for matching both levels of blood glucose and blood pressure with the liraglutide group. A control group was injected only a vehicle. Results: Control group exhibited hyperglycemia and hypertension, whereas two treatment groups similarly reduced both blood glucose and blood pressure levels. While retinal thickening for the retinal edema was found in control group, the degree was significantly prevented in the liraglutide group. Furthermore, the effect was also brought by the treatments of both insulin and hydralazine. Conclusions: Liraglutide prevented the retinal edema characterized in the early phase of diabetic retinopathy via reduction of both blood glucose and blood pressure levels. |